2.60Open2.60Pre Close0 Volume2 Open Interest21.00Strike Price0.00Turnover117.91%IV-0.38%PremiumJan 17, 2025Expiry Date2.67Intrinsic Value100Multiplier23DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.6195Delta0.0705Gamma4.76Leverage Ratio-0.0437Theta-0.0083Rho-2.95Eff Leverage0.0175Vega
Pulse Biosciences Stock Discussion
Pulse Biosciences, Inc. Announces Successful Treatment of Patients in First-in-Human Study With Its Nano-Pfa Cardiac Surgery System
1 MINUTE AGO, 8:00 AM EST
VIA BUSINESSWIRE
No comment yet